Date Name Title Filing Type Shares Traded Price Total Held
Jan 13, 2003
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Bona fide gift 250 $19.65 15,482
Dec 15, 2003
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,977 -- 17,441
Dec 15, 2003
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,692 -- 7,692
Dec 15, 2003
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 92,308 -- 92,308
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 80 $15.66 17,361
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 27 $15.60 17,334
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 80 $15.57 17,254
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 27 $15.53 17,227
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 27 $15.48 17,200
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 27 $15.47 17,173

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.